BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Talk to Sales

  Get in touch with our sales team to discuss how BioSpace can help you meet your business goals, whether it’s advertising, recruitment marketing or thought leadership.

  August 23, 2024
• 

  COVID-19

  FDA Greenlights Updated COVID-19 Shots from Pfizer, Moderna for Fall Season

  The regulator on Thursday said the mRNA vaccines, Pfizer-BioNTech’s Comirnaty and Moderna’s Spikevax, will better protect against currently circulating variants as COVID continues to surge in many parts of the U.S.

  August 23, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Gene editing

  Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching

  Despite the promise of its technology and funding from big backers, Tome Biosciences is “operating at reduced capacity” and weighing its “strategic options” as the Massachusetts-based company faces an uncertain future.

  August 23, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Stomach cancer

  FDA Sets Adcomm Meeting to Assess Checkpoint Inhibitors in Stomach Cancer Using PD-L1

  The Oncologic Drugs Advisory Committee in a Sept. 26 meeting will discuss whether the regulator should restrict approval of checkpoint inhibitors based on PD-L1 expression levels.

  August 23, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Editorial

  Would Trump Repeal the Inflation Reduction Act if Elected?

  Project 2025, a blueprint for a potential second Trump term that highlights the IRA as a potential target, took a starring role in this week’s Democratic National Convention.

  August 23, 2024

   · 

  4 min read

   · 

  Greg Slabodkin
• 

  Deals

  Biopharma VC Funding in Q2 Reaches Highest Quarterly Level Since 2022

  Venture capital in the sector hit $9.2 billion in the second quarter of 2024, up from $7.4 billion in Q1, while exits fell on a slower M&A cycle and picky IPO market.

  August 23, 2024

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Earnings

  Bavarian Nordic Adopts Optimistic Outlook Amid New Orders for Mpox Vaccine

  The Danish biotech on Thursday reported stronger-than-expected earnings and forecasts hitting the upper range of its full-year revenue target amid the ongoing mpox outbreak.

  August 23, 2024

   · 

  1 min read

   · 

  Tristan Manalac
• Press Releases

  Centinel Spine’s Leadership in Lumbar Total Disc Replacement Fueled Through Rapidly Expanding Market and Long-Term Survivability Data

  August 23, 2024

   · 

  6 min read
• Press Releases

  10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

  August 23, 2024

   · 

  1 min read
• Press Releases

  Antengene Announces 2024 Interim Financial Results, Highlights Progress in R&D and Commercialization

  August 23, 2024

   · 

  9 min read